Notal Vision Revenue and Competitors

Location

$85.1M

Total Funding

Estimated Revenue & Valuation

  • Notal Vision's estimated annual revenue is currently $28.4M per year.(i)
  • Notal Vision's estimated revenue per employee is $251,000
  • Notal Vision's total funding is $85.1M.

Employee Data

  • Notal Vision has 113 Employees.(i)
  • Notal Vision grew their employee count by -16% last year.

Notal Vision's People

NameTitleEmail/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$382.1M40627%$850M$1.2B
Add Company

What Is Notal Vision?

Notal Vision, makers of ForeseeHome, was founded in 2000 by ophthalmologists and medical device professionals determined to reduce vision loss associated with age-related macular degeneration (AMD). With leading experts in the field, this team of medical professionals and scientists developed a new, patented technology for monitoring AMD. This new technology, Preferential Hyperacuity Perimetry, is now providing eye care professionals around the world with valuable clinical data for monitoring patients with AMD.

keywords:Biotechnology,Healthcare,Medical Devices,Medical Diagnostics,Pharmaceuticals

$85.1M

Total Funding

113

Number of Employees

$28.4M

Revenue (est)

-16%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Notal Vision News

2022-04-20 - The offerings and limitations of digital health care in ...

After a referring physician determines a patient with dry intermediate AMD is well suited for home monitoring, the Notal Vision Monitoring...

2022-03-22 - Notal Vision Reports Publication of First US Home OCT

The Notal OCT Analyzer (NOATM), a proprietary deep learning algorithm, developed in-house, performs automated analysis of the Home OCT scans and...

2022-03-22 - Addressing the need for greater access in vision care

An example of this already in use is the ForeseeHome system from Notal Vision, which uses algorithms to alert doctors to statistically...

2021-06-01 - Notal Vision raises up to $60 million to support development of its Home OCT technology and commercial growth of its ForeseeHome AMD Monitoring Program

Manassas, VA, June 01, 2021 (GLOBE NEWSWIRE) -- Notal Vision, Inc., a privately held ophthalmic home monitoring services provider focused on early disease detection and treatment monitoring is pleased to announce the closing of a Series D financing co-led by Soleus Capital and the company’s majo ...

2021-06-01 - Notal Vision raises $60 million to support development of its Home OCT technology

Notal Vision has announced the closing of a Series D financing round of up to $60 million co-led by Soleus Capital and the company’s majority shareholder Ganot Capital

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$27.1M123-4%N/A
#2
$34.6M1284%N/A
#3
N/A147-1%N/A
#4
$47.2M1484%N/A
#5
$44.6M150-6%N/A